Table: Rohto - 6-MTH group results

Rohto Pharmaceutical

13/11/2025 06:32

Nov 13 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              164.26              139.08           338.50    
                   (+18.1 pct)         (+8.8 pct)       (+9.7 pct)  
  Operating           19.32               17.79            39.50    
                   (+8.6 pct)          (-15.1 pct)      (+3.3 pct)  
  Recurring           24.61               18.59            44.00    
                   (+32.4 pct)         (-18.0 pct)      (+10.8 pct) 
  Net                 17.65               12.92            32.00    
                   (+36.6 pct)         (-22.1 pct)      (+3.8 pct)  
  EPS               78.12 yen           56.64 yen       141.62 yen  
  EPS Diluted       76.32 yen           56.47 yen                   
  Ann Div                               36.00 yen        43.00 yen  
  -Q2 div           21.00 yen           16.00 yen                   
  -Q4 div                               20.00 yen        22.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T